By injecting agonistic CD137 monoclonal antibody (mAb), reduction in glomerulonephritis in MRL/lpr mice was demonstrated, besides reduction in CD4+ lymphocytes, anti-dsDNA production, germinal centre formation in secondary lymphoid organs, and mortality [65]. Here, TNFRSF9 is linked to glomerulonephritis.